Dr. Kapilkumar Nalinbhai Patel, MD

Dr. Patel practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Patel's NPI, 1356416531, was assigned on November 22, 2006. Dr. Patel graduated from Medical University of Lublin in 2001. Dr. Patel holds Florida license ME128843.

Dr. Patel's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Patel's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. Dr. Patel is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Patel to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Patel is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Patel's licenses on file in 7 states: Florida, California, North Carolina, Maryland, Nebraska, New York and Vermont.

Dmand AI lists chronic lung disease, pneumonia, pneumonia and respiratory infection and pulmonary fibrosis among the conditions Dr. Patel treats.

CMS data shows 611 Medicare services from Dr. Patel across 10 procedure codes in 2024, for 148 Medicare patients. Medicare paid $51,327 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 3.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 71, with 49% women.

In 2024, Dr. Patel wrote 6,461 Medicare Part D claims for 314 patients. 77% of them were for generic drugs. CMS names the drug for 5,852 of them, across 101 drugs with 11 or more claims each, at $8,289,615 in total drug cost. In 2023, CMS named 7,695 claims across 116 drugs.

Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Patel, published from 2016 to 2024. 2022 was the busiest year, with 2. The most frequent topics are COVID-19, Cytokines and SARS-CoV-2. Dr. Patel's most frequent co-authors are Debabrata Bandyopadhyay, MD, Lucy Guerra, MD and Jose David Herazo-Maya, MD.

Dmand AI links Dr. Patel to 2 clinical trials. Conditions studied include Cystic Fibrosis, Rejection, Psychology and Infant, Newborn, Diseases.

CMS Open Payments shows 187 general payments to Dr. Patel from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Gilead Sciences, Inc. paid the most, $22,285.

Dmand AI lists 1 award for Dr. Patel, most recently CMS Stage 1 EHR in 2013.

Dr. Patel graduated from Medical University of Lublin in 2001.

Dr. Patel is in network with 12 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.